Indogulf Cropsciences
Q2 revenue +3% to ₹255.8 Cr; EBITDA +27%, margin 16% (13%) on mix and cost cuts. H1 revenue -3%, negative operating cash flow, inventory elevated.
ALFA Concalls
Every earnings call, live and summarised
Earnings calls
Every Indogulf Cropsciences earnings call we streamed: the live audio and our summary of what management said.
Q2 revenue +3% to ₹255.8 Cr; EBITDA +27%, margin 16% (13%) on mix and cost cuts. H1 revenue -3%, negative operating cash flow, inventory elevated.
Q2 revenue +3% to ₹255.8 Cr; EBITDA +27%, margin 16% (13%) on mix and cost cuts. H1 revenue -3%, negative operating cash flow, inventory elevated.
Q3 FY27 'challenging'; industry bottom Oct–Dec 2026, recovery Q1 FY28; no margin or revenue guidance; H2 OCF positive expected.
Indogulf Cropsciences reported 19% YoY revenue growth in FY26, driven by a diversified product mix and domestic expansion. PAT grew 27% YoY due to higher-margin specialty products and operating leverage.
Indogulf delivered strong FY26 performance with 19% revenue growth and 27% PAT growth, driven by its Crop Protection vertical and expansion into new international markets.
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.